{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:40:04Z","timestamp":1749948004383,"version":"3.41.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Managing health care acquired and device-associated intracranial infections in young children can be challenging given adverse antibiotic side effects and difficulties in achieving adequate central nervous system (CNS) antibiotic concentrations. Ceftaroline is a cephalosporin with a favorable safety profile and activity against methicillin-resistant <jats:italic toggle=\"yes\">Staphylococci<\/jats:italic> and several Gram-negative organisms. Published data on the use of ceftaroline for CNS infections in children and adults are limited.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We describe a 2-month-old infant with ventriculo-subgaleal shunt-associated methicillin-resistant <jats:italic toggle=\"yes\">Staphylococcus epidermidis<\/jats:italic> ventriculitis, which was successfully treated with ceftaroline, in addition to vancomycin and rifampin. We conducted a scoping review of English-language literature retrieved from PubMed, EMBASE and Web of Science that assessed the use of ceftaroline for CNS infections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We identified 22 articles for inclusion in our review, which described 92 unique patients, of whom 2 were &lt;21 years old. Ceftaroline was commonly used in conjunction with other antibiotics to treat infections caused by <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>, coagulase-negative <jats:italic toggle=\"yes\">Staphylococci<\/jats:italic> and <jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic>. Most case reports described clinical success with ceftaroline, though small case series and cohort studies yielded mixed efficacy assessments. Adverse effects attributed to ceftaroline were rare and included reversible myelosuppression, eosinophilia, hepatotoxicity and nephrotoxicity. Pharmacokinetic\/pharmacodynamic studies suggested similar CNS penetration through inflamed meninges as other beta lactam antibiotics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>We identified a growing body of published evidence supporting the use of ceftaroline in combination with other agents for the treatment of CNS infections. In absence of clinical trials, additional real-world data are needed to define the efficacy and safety of ceftaroline for children and adults with CNS infections.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004310","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T19:00:59Z","timestamp":1709838059000},"page":"663-668","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Ceftaroline for Central Nervous System Infections: Case Report of a Young Infant, and Scoping Review"],"prefix":"10.1097","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-3578","authenticated-orcid":false,"given":"Haley","family":"Urbach","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Yale New Haven Children\u2019s Hospital, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Sileo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Lerma","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Boston Medical Center, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, St. Christopher\u2019s Hospital for Children, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giordano","family":"Sosa Soto","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Boston Medical Center, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Heiderich","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Boston Medical Center, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Holsapple","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Boston Medical Center, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Vuppula","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Boston Medical Center, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey I.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Boston Medical Center, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"piad064","DOI":"10.1093\/jpids\/piad064","article-title":"Associations of standard care, intrathecal antibiotics, and antibiotic impregnated catheters with cerebrospinal fluid shunt infection organisms and resistance.","volume":"12","author":"Sedano","year":"2023","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/AAC.01604-15","article-title":"Observed antagonistic effect of linezolid on daptomycin or vancomycin activity against biofilm-forming methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model.","volume":"59","author":"Luther","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1128\/AAC.47.9.3002-3004.2003","article-title":"Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.","volume":"47","author":"Chiang","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1128\/AAC.00237-09","article-title":"In vitro 24-hour time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus.","volume":"53","author":"Singh","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"piad032","DOI":"10.1093\/jpids\/piad032","article-title":"Time for a change: considering vancomycin alternatives for pediatric methicillin-resistant Staphylococcus aureus bacteremia.","volume":"12","author":"Haynes","year":"2023","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/INF.0000000000004023","article-title":"Safety and efficacy of ceftaroline in neonates with staphylococcal late-onset sepsis: a case series analysis.","volume":"42","author":"Callies","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijantimicag.2019.06.025","article-title":"Off-label use of ceftaroline fosamil: a systematic review.","volume":"54","author":"Pani","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"ofx084","DOI":"10.1093\/ofid\/ofx084","article-title":"Ceftaroline for severe methicillin-resistant Staphylococcus aureus infections: a systematic review.","volume":"4","author":"Cosimi","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1128\/AAC.00484-13","article-title":"Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.","volume":"57","author":"Sader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-20250614","first-page":"466","article-title":"A side effect of ceftaroline in MRSA meningitis treatment.","volume":"67","author":"Verdecia","year":"2019","journal-title":"J Investig Med"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/phar.1596","article-title":"Agranulocytosis with ceftaroline high-dose monotherapy or combination therapy with clindamycin.","volume":"35","author":"Varada","year":"2015","journal-title":"Pharmacotherapy"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1128\/AAC.04965-14","article-title":"Examining the use of ceftaroline in the treatment of Streptococcus pneumoniae meningitis with reference to human cathelicidin LL-37.","volume":"59","author":"Sakoulas","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.wneu.2020.01.013","article-title":"Multidrug-resistant Staphylococcus epidermidis ventriculostomy-related infection successfully treated by intravenous ceftaroline after failure of daptomycin treatment.","volume":"136","author":"Roujansky","year":"2020","journal-title":"World Neurosurg"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/jac\/dku464","article-title":"Ceftaroline CSF concentrations in a patient with ventriculoperitoneal shunt-related meningitis.","volume":"70","author":"Kuriakose","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2146\/ajhp130246","article-title":"Methicillin-resistant Staphylococcus aureus epidural abscess treated with ceftaroline fosamil salvage therapy.","volume":"71","author":"Bucheit","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/jac\/dku392","article-title":"Successful use of ceftaroline for the treatment of MRSA meningitis secondary to an infectious complication of lumbar spine surgery.","volume":"70","author":"Balouch","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R17-20250614","first-page":"336","article-title":"Ceftaroline cerebrospinal fluid penetration in the treatment of a ventriculopleural shunt infection: a case report.","volume":"25","author":"Cies","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/IPC.0000000000000431","article-title":"Early cerebritis resulting in a first-time seizure in an otherwise healthy young man.","volume":"24","author":"Jenks","year":"2016","journal-title":"Infect Dis Clin Pract"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.wneu.2017.11.082","article-title":"Rare concurrent retroclival and pan-spinal subdural empyema: review of literature with an uncommon illustrative case.","volume":"110","author":"Mortazavi","year":"2018","journal-title":"World Neurosurg"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"101640","DOI":"10.1016\/j.ajoc.2022.101640","article-title":"Pediatric cavernous sinus and superior ophthalmic vein thrombophlebitis complicated by peri-venous orbital abscesses.","volume":"27","author":"Swiatek","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/IPC.0b013e318276959f","article-title":"Use of ceftaroline in the management of vertebral osteomyelitis case report.","volume":"21","author":"Zainah","year":"2013","journal-title":"Infect Dis Clin Pract (Baltim Md)"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/jpc.1_15604","article-title":"Rare cause of scalp swelling in an infant.","volume":"58","author":"Dix-Matthews","year":"2022","journal-title":"J Paediatr Child Health"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.medin.2021.05.011","article-title":"Ceftaroline versus standard therapy for pneumococcal meningitis in critically ill patients.","volume":"46","author":"Martin-Cerezuelaa","year":"2022","journal-title":"Med Intensiva (Engl Ed)"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/jac\/dkw062","article-title":"High incidence of neutropenia in patients with prolonged ceftaroline exposure.","volume":"71","author":"Furtek","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s40265-017-0785-2","article-title":"Early use of ceftaroline fosamil in the United States veterans health care system.","volume":"77","author":"Britt","year":"2017","journal-title":"Drugs"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"115","DOI":"10.37201\/req\/119.2020","article-title":"Ceftaroline fosamil: clinical experience after 23-month prescription in a tertiary hospital.","volume":"34","author":"Alonso \u00c1lvarez","year":"2021","journal-title":"Rev Esp Quimioter"},{"key":"R27-20250614","first-page":"A43","article-title":"Clinical experience of ceftaroline use in a third level hospital.","volume":"28","author":"Magallon Martinez","year":"2021","journal-title":"Eur J Hosp Pharm"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/ofid\/ofac492.141","article-title":"Ceftaroline for central nervous system and ocular infections.","volume":"9","author":"Siegrist","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jgar.2018.01.001","article-title":"DISC: describing infections of the spine treated with ceftaroline.","volume":"13","author":"Watkins","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/sur.2014.098","article-title":"A pharmacokinetic\/pharmacodynamic analysis of ceftaroline prophylaxis in patients with external ventricular drains.","volume":"16","author":"Stein","year":"2015","journal-title":"Surg Infect (Larchmt)"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/jac\/dky489","article-title":"Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drain.","volume":"74","author":"Chauzy","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/cid\/cir147","article-title":"Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus.","volume":"52","author":"Saravolatz","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1586\/14787210.2015.1077700","article-title":"Bacterial meningitis: an update of new treatment options.","volume":"13","author":"Nau","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"e0074122","DOI":"10.1128\/aac.00741-22","article-title":"Population pharmacokinetic modeling and probability of target attainment of ceftaroline in brain and soft tissues.","volume":"66","author":"Helfer","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"e229114","DOI":"10.1136\/bcr-2018-229114","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA) sepsis complicated by warm autoimmune haemolytic anaemia secondary to antimicrobial therapy.","volume":"12","author":"Verdecia","year":"2019","journal-title":"BMJ Case Rep"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"e02622","DOI":"10.1128\/AAC.02622-18","article-title":"Treatment of multidrug-resistant vancomycin-resistant Enterococcus faecium hardware-associated vertebral osteomyelitis with oritavancin plus ampicillin.","volume":"63","author":"Dahesh","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:03:42Z","timestamp":1749945822000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004310","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2024,3,4]]}}}